Global adoption growing with more than 400 institutions across 33 countries ordering DNA constructs up to 49.1 kb, with ...
Delivering CRISPR-Cas9 as mRNA in lipid nanoparticles preserved the fitness and erythroid potential of edited human ...
(Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in ...
–ARIA investment advances QBI's landmark Science study, accelerating the path from molecular discovery to new precision ...
Researchers have used a novel CRISPR-Cas library to identify essential microRNAs in prostate cancer cells, revealing miR-483-3p as a key regulator of cell survival. The study found that disrupting ...
A new sensitive method detects large-scale chromosomal rearrangements caused by CRISPR-Cas9 genome editing in primary human cells. The approach reveals that palbociclib can prevent these unwanted ...
An new end-to-end nomination workflow improves the nomination of genomic sites that may be unintentionally edited by CRISPR-Cas, combining high analytical sensitivity with a comparatively manageable ...
In vivo genome editing is entering an important new phase. Advances in editing technologies, delivery platforms and translational science are bringing the prospect of one-time, directly administered ...
An new end-to-end nomination workflow improves the nomination of genomic sites that may be unintentionally edited by CRISPR-Cas, combining high... Triple Base Editor Diversifies Three Nucleotides... A ...
A novel genome-editing platform addresses one of the field's most constant challenges – how to insert kilobase-scale DNA into living cells without... Highlight: Tripartite complex boosts non-viral ...
Intellia Therapeutics has reported positive three-year follow-data from the ongoing Phase 1/2 trial of lonvo-z (formerly known as NTLA-2002) in patients with hereditary angioedema. The data show that ...
SNIPR Biome has dosed the first patient in its Phase 1b trial of SNIPR001, a CRISPR-CAS-armed bacteriophage therapy that represents a new frontier in precision antimicrobial treatment. The randomised, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results